Compare Edwards Lifesciences Corporation Common Stock (EW) vs Onto Innovation (ONTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Onto Innovation — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Onto Innovation trades at $297.41 (market cap $14.94B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 3.3× Onto Innovation's market cap, and Onto Innovation is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | ONTO | |
|---|---|---|
Market Cap | $49.44B | $14.94B |
Volume | 3,508,027 | 933,124 |
Sector | Health | Technology |
52-Week High | $95.18 | $378.45 |
52-Week Low | $72.65 | $121.34 |
Enterprise Value | $45.90B | $14.53B |
Typical Hold Time | — | 5 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Onto Innovation
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →
